A retatrutide before and after is the weakest evidence for the best evidenced compound here
The trial exists and the approval does not. Retatrutide holds no marketing authorisation in any country, so no pharmacy can dispense it and no clinician can prescribe it, which is the whole reason anybody is scrolling through photographs of strangers in the first place.
When a trial exists, a photograph adds nothing to the efficacy question. It can only add noise, and in this market it usually adds a purchase link.
Everywhere else on this site, before and after posts fill a vacuum. For those compounds no human efficacy trial exists, so people reach for whatever they can find.
Here the vacuum is not there. Jastreboff and colleagues randomised adults with obesity to placebo or to escalating amounts, ran the study for 48 weeks, and reported mean weight reduction of roughly 24 percent in the group receiving the highest amount studied, 12 mg weekly. That is a controlled comparison with a placebo group, in a population defined in advance, with results published whichever way they came out.
Set a pair of photographs from an anonymous account beside that. The photographs have no comparison group, no verification that the person took what they say they took, no confirmation of what was in the vial, no record of what else changed in their life, and no obligation on anyone to publish the ones where it did not work.
The trial already answered the question these photographs are asking
Be precise about what has and has not been settled, because both directions get overstated.
Settled by the trial: that this compound produces substantial weight reduction over 48 weeks in adults with obesity who meet the entry criteria, when given as the manufacturer's product with gradual escalation and clinical supervision.
Not settled by anything: what happens beyond that period, what happens after stopping, how it compares head to head against the licensed medicines in the same class, which it is not among, and what happens when an unverified vial is used by an unscreened person with nobody watching.
Notice that a before and after post cannot help with the second list either. It is too small, too selected, and too unverified to answer any of it. So the posts are redundant where evidence exists and useless where it does not.
What a scale reading cannot tell you about what was lost
Even taken at face value, the numbers in these posts measure something cruder than the reader thinks.
A scale reports total mass. It does not separate fat from lean tissue from fluid, and rapid weight reduction from any cause involves more than fat. Whether lean mass is preserved during large reductions is a live question across this whole class of drugs, and no published human work establishes an answer for this compound specifically. A post claiming that the weight lost was all fat is asserting something the person has no way of knowing.
The same applies to the outcomes that actually matter over a lifetime. Blood pressure, blood sugar, liver measures and cardiovascular risk are the reasons weight reduction is pursued medically, and none of them appears in a photograph. A trial measures them. A mirror does not.
Two records of the same 48 weeks
The final column is the whole difference. A trial is obliged to count the people it disappointed. Every other row on that table is a collection of survivors, and adding more of them changes nothing about the selection.
| What is offered | Who is included | What is verified | What happens to disappointing results |
|---|---|---|---|
| Published Phase 2 trial | Every enrolled human, including those who withdrew | The product, the amounts, the measurements | Reported |
| A pair of photographs online | One human, self selected | Nothing | Never posted |
| A clinic's own client gallery | Humans the clinic chose to feature | Nothing external | Filtered before publication |
| A long running personal thread | One human, still posting because it went well | Nothing | The person stops posting |
| A supplier's testimonials page | Humans selected by the seller | Nothing | Excluded by design |
The part of these accounts that no trial can supply
Having said all that, there is one thing these posts document that the published trial genuinely cannot, and it is worth reading them for.
The trial describes what happens when a verified pharmaceutical product is given to screened participants under supervision. Nobody has studied what happens when unverified powder from an uninspected supplier is reconstituted at a kitchen table by someone who was never screened. That experience exists only in these accounts.
So read them for the parts nobody is advertising. Read the posts describing vials that arrived with the wrong labelling, or that produced no effect at all, which points at a product that was not what it claimed. Read the ones describing gastrointestinal effects severe enough to stop, and notice that there was nobody to call. Read the ones where a supplier disappeared mid course. Read the ones asking whether a symptom is normal, and notice that the answers come from strangers.
That material is the honest content of this genre. It is a record of what the unregulated route is like in practice, and it is far more informative than any photograph.
The timing that almost no post survives
There is one structural feature of these accounts worth checking before anything else, and it is easier to spot than any of the tells below.
Ask when the post was written relative to when the person started. The overwhelming majority appear in the first few months, at the point where the effect is largest and the enthusiasm is highest. Very few are written at eighteen months. Almost none are written a year after stopping, which is the moment a reader considering this actually wants to know about.
That is not a coincidence and it is not dishonesty. People post when something is going well and go quiet when it is not, and the market's supply of accounts is shaped entirely by that. The result is a body of material describing the beginning of an experience, presented as though it described the whole of it.
The trial has the same limit, honestly stated: it ran 48 weeks, and it reports 48 weeks. The difference is that the trial says so, and the Phase 3 programme exists to extend it. A gallery of early results says nothing about its own boundary, and the reader supplies the assumption that the pictures represent a settled state.
The tells that mark a post as advertising
Not every account is commercial, and assuming otherwise would be lazy. Plenty are people describing what they think happened to them.
Some are not, and this compound attracts more of it than most because the market is large and the demand is intense. The signals are consistent: a discount code, a supplier tagged or named repeatedly, an account whose entire history concerns one product, phrasing lifted directly from a seller's own marketing, comments disabled or curated, and a striking absence of anything difficult. Real experiences of this drug class include weeks of feeling unwell. A journey with no bad days in it has been edited.
The point is not that a paid post is necessarily false. It is that it passed through a filter, and the accounts that went badly were removed before you saw them.
Why a supervised arm is not the same journey
The last thing worth separating is the person in the photograph from the participant in the trial, because they are not doing the same thing.
The participant received a product of known identity and strength. They were screened, so conditions that would make the drug dangerous for them were found first. Their amount was escalated under supervision, with someone able to hold a step when they struggled. They attended appointments where measurements were taken. They had a route to report a problem and someone obliged to act on it. And they had trial support around diet and activity, which is a real part of what produced the result.
The person posting has a vial and a syringe. Comparing their outcome with the trial figure treats the drug as the only variable, when the trial's own design says otherwise.